1. Home
  2. FGEN vs MTEN Comparison

FGEN vs MTEN Comparison

Compare FGEN & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • MTEN
  • Stock Information
  • Founded
  • FGEN 1993
  • MTEN 2015
  • Country
  • FGEN United States
  • MTEN China
  • Employees
  • FGEN N/A
  • MTEN N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • MTEN Building Products
  • Sector
  • FGEN Health Care
  • MTEN Industrials
  • Exchange
  • FGEN Nasdaq
  • MTEN Nasdaq
  • Market Cap
  • FGEN 34.5M
  • MTEN 36.6M
  • IPO Year
  • FGEN 2014
  • MTEN 2024
  • Fundamental
  • Price
  • FGEN $0.46
  • MTEN $5.35
  • Analyst Decision
  • FGEN
  • MTEN
  • Analyst Count
  • FGEN 0
  • MTEN 0
  • Target Price
  • FGEN N/A
  • MTEN N/A
  • AVG Volume (30 Days)
  • FGEN 727.9K
  • MTEN 105.2K
  • Earning Date
  • FGEN 02-24-2025
  • MTEN 10-18-2024
  • Dividend Yield
  • FGEN N/A
  • MTEN N/A
  • EPS Growth
  • FGEN N/A
  • MTEN N/A
  • EPS
  • FGEN N/A
  • MTEN 0.13
  • Revenue
  • FGEN $180,015,000.00
  • MTEN $9,136,855.00
  • Revenue This Year
  • FGEN $21.91
  • MTEN N/A
  • Revenue Next Year
  • FGEN N/A
  • MTEN N/A
  • P/E Ratio
  • FGEN N/A
  • MTEN $41.42
  • Revenue Growth
  • FGEN 16.15
  • MTEN 18.30
  • 52 Week Low
  • FGEN $0.18
  • MTEN $1.81
  • 52 Week High
  • FGEN $2.80
  • MTEN $9.87
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 41.72
  • MTEN N/A
  • Support Level
  • FGEN $0.46
  • MTEN N/A
  • Resistance Level
  • FGEN $0.51
  • MTEN N/A
  • Average True Range (ATR)
  • FGEN 0.04
  • MTEN 0.00
  • MACD
  • FGEN -0.01
  • MTEN 0.00
  • Stochastic Oscillator
  • FGEN 6.59
  • MTEN 0.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.

Share on Social Networks: